Log in to save to my catalogue

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and di...

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and di...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cd6f8a1f9ab4438a9737135f0568f91e

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention

About this item

Full title

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention

Publisher

England: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2022-12, Vol.21 (1), p.270-270, Article 270

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The newly proposed term "metabolic dysfunction-associated fatty liver disease" (MAFLD) is replacing the old term "non-alcoholic fatty liver disease" (NAFLD) in many global regions, because it better reflects the pathophysiology and cardiometabolic implications of this common liver disease. The proposed change in terminology from NAFLD to MAFLD is n...

Alternative Titles

Full title

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cd6f8a1f9ab4438a9737135f0568f91e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cd6f8a1f9ab4438a9737135f0568f91e

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-022-01697-0

How to access this item